Concepedia

Christina Vianden

CV

Statistics

Publications

4

Citations

370

H-Index

4

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Nektar Therapeutics (United States)

University of Virginia

The University of Texas Health Science Center at Houston

Yale University

Christina Vianden is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, immunotherapy, and cancer immunology.

Publications per year

2016–2020

4

Publications

4

Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy

Meenu Sharma, Hiep Khong, Faisal Fa’ak et al. · Nature Communications · 2020 · 169 citations · Full text

, , +17

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain

Manisha Singh, Christina Vianden, Mark J. Cantwell et al. · Nature Communications · 2017 · 103 citations · Full text

, , +17

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy

Yared Hailemichael, Amber N. Woods, Tihui Fu et al. · Journal of Clinical Investigation · 2018 · 81 citations · Full text

, , +17

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

, , +17

1–4 of 4